The Role of Ribose in Patients Diagnosed With Fibromyalgia
Not Applicable
Suspended
- Conditions
- Fibromyalgia
- Interventions
- Dietary Supplement: D-riboseOther: dextrose
- Registration Number
- NCT00566514
- Lead Sponsor
- Bioenergy Life Science, Inc.
- Brief Summary
The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.
- Detailed Description
Two hundred to three hundred subjects (equally distribued between placebo and D-ribose) between 18-78 years of age will comprise this study. The final numbers enrolled will depend upon obtaining approximately 100 subjects that can display a high degree of compliance to TID dosing with approximately equal balance between the active and placebo arms.
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- previous diagnosis of fibromomyalgia by a MD
- Has been diagnosed with fibromyalgia and are over 18 years of age
- Does live in the United States
Exclusion Criteria
- does NOT have severe medication/chemical/supplement sensitivities
- does NOT have insulin dependent diabetes or other severe illnesses (cancer, hepatitis, congestive heart failure)
- does NOT have rheumatoid arthritis or gout
- previous use of ribose
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 D-ribose D-ribose 5 grams TID orally 2 dextrose Dextrose 5 grams TID
- Primary Outcome Measures
Name Time Method Significant reduction in symptoms of pain and fatigue 3 weeks
- Secondary Outcome Measures
Name Time Method Demonstrate an improvement in ones quality of life 3 weeks
Trial Locations
- Locations (1)
Bioenergy Life Science, Inc.
🇺🇸Minneapolis, Minnesota, United States